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espiratory Epidemiology, Occupational Medicine and Public Health Group, National Heart and Lung Institute, Imperial College London, United KingdomDiet has been a constant determinant of social, economic and
isease across history. One of the transformational eras in diet prob-
bly started during the Tudor period (1458–1603). This was  a time
f great creativity, and one of intellectual, political and religious
enovation. This period would also see the discovery and introduc-
ion of sugar to the diet (a privilege reserved for the wealthiest),
nd its use in preserving fruits. Bread, meat, ﬁsh, pottages and
ine formed the basis of most diets. Although fresh fruits and veg-
tables were available, it was common for people to avoid eating
hem uncooked, believing them to carry disease. Indeed, during the
lague of 1569 the selling of fresh fruit was banned by law.1
In modern times, the introduction of evidence-based medicine
as been fundamental to improve our understanding of the role
f risk factors on disease. It has also been pivotal to enable the
cientiﬁc and clinical community to establish recommendations
nd care plans for patients and populations at high risk of disease.
lind randomised controlled trials (RCTs) are usually considered
he gold standard in evidence-based medicine. The evidence from
uch interventions is often used as reference to provide recommen-
ations to patients. In the case of diet, there are several limitations
nherent to this exposure, which make evidence-based applications
ore difﬁcult. RCTs investigating the effect of diet on disease have
ften used a single nutrient or a combination of them given as sup-
lements. Evidence from such trials has led to important public
ealth recommendations in some cases. For example, large trials
n vitamin A supplementation in Nepal2 have shown a signiﬁcant
ecrease in mortality in vulnerable populations of children. This
ed to nationwide programmes of supplementation in children,
nd until adequate and reliable dietary sources of vitamin A can
e made accessible to the target populations, the supplementation
rogrammes will offer the safest way to deliver this nutrient. More
ecently, Public Health England recommends that all those above
ge 1 year take a vitamin D supplement on a regular basis to coun-
eract the health effects caused by the endemic deﬁciency observed
n the general population. This advice is based on the recommen-
ations of the Scientiﬁc Advisory Committee on Nutrition (SACN)
ollowing its review of the evidence on vitamin D and health.3
Studies in vitro and in vivo continue to provide insight into
he mechanisms through which diet could modulate disease. Yet,
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difﬁcult due to several issues such as (a) blinding, (b) sample size
calculations, (c) time of follow-up, which can be better addressed
in a pragmatic RCT. Blinding is a major methodological limitation
as patients can rarely be blinded to what food they are eating,
and the intervention might be obvious to the researchers. This
issue is particularly relevant when population-based interventions
are planned, as biases from both, patient and investigator will
occur. To compensate for the lack of blinding, concealment of
randomisation is still important, as is blinding the assessor of
outcomes.4 On the other hand, estimating the sample size needed
for a food intervention may  not follow the same rationale as
that of a pharmacological or drug-related RCT. Finally, diet can be
considered a ‘chronic exposure’ and it is often unclear how long the
intervention will need to last until changes in health outcome are
measured.
A major challenge remains to improve the adherence of the
population to recommendations. The current recommendation
of eating ﬁve portions of fruits and vegetables a day is being
met  by less than 15% of adults in the US5, and by less than
half of the adults in Europe. This, at a time of increasingly
robust evidence from observational studies and high quality sys-
tematic review, suggesting that diet could modulate the risk
of disease. Speciﬁc diets (e.g. Mediterranean), natural sources
of antioxidants, or foods with anti-inﬂammatory properties (e.g.
vegetables) have all been proposed to reduce the severity and
burden of several non-communicable chronic diseases, including
neurological, autoimmune, and inﬂammatory-mediated illnesses.
However, as shown by the ﬁgures on fruit and vegetable intake,
introducing sustained changes in diet, regardless of how small, is
difﬁcult.
Evidence-based medicine will continue to represent a major
tool to improve the health of the population. In particular,
evidence-based nutrition recommendations that can be success-
fully implemented in the population are urgently needed to tackle
the current trends in chronic morbidity. The Porto Biomedical Jour-
nal will welcome studies that help to strengthen the evidence on
the role of lifestyle-related risk factors for disease.References
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